 | • レポートコード：MRC23Q38205 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（2-3日） • 産業分類：医薬品 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界のPIG豚繁殖呼吸器症候群（PRRS）ワクチン市場について調査・分析し、世界のPIG豚繁殖呼吸器症候群（PRRS）ワクチン市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（CH-1R株、PC株、その他）、用途別セグメント分析（雌豚、雌豚）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Merck、HIPRA、Sinopharm Animal Health Co., Ltd、Ceva Santé Animale、CAVAC、Bioveta、Jinyu Bio-Technology、Zoetis、Boehringer Ingelheim、Harbin Pharmaceutical Groupなどが含まれています。 世界のPIG豚繁殖呼吸器症候群（PRRS）ワクチン市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、PIG豚繁殖呼吸器症候群（PRRS）ワクチン市場規模を推定する際に考慮しました。本レポートは、PIG豚繁殖呼吸器症候群（PRRS）ワクチンの世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、PIG豚繁殖呼吸器症候群（PRRS）ワクチンに関するビジネス上の意思決定に役立てることを目的としています。 ・PIG豚繁殖呼吸器症候群（PRRS）ワクチン市場の概要 - 製品の定義 - PIG豚繁殖呼吸器症候群（PRRS）ワクチンのタイプ別セグメント - 世界のPIG豚繁殖呼吸器症候群（PRRS）ワクチン市場規模：タイプ別分析（CH-1R株、PC株、その他） - PIG豚繁殖呼吸器症候群（PRRS）ワクチンの用途別セグメント - 世界のPIG豚繁殖呼吸器症候群（PRRS）ワクチン市場規模：用途別分析（雌豚、雌豚） - 世界のPIG豚繁殖呼吸器症候群（PRRS）ワクチン市場規模予測（2018年-2029年） - PIG豚繁殖呼吸器症候群（PRRS）ワクチンの平均価格推移（2018年-2029年） - 前提条件と制限事項 ・メーカー別競争状況 - メーカー別市場シェア - 世界の主要メーカー、業界ランキング分析 - メーカー別平均価格 - PIG豚繁殖呼吸器症候群（PRRS）ワクチン市場の競争状況およびトレンド ・PIG豚繁殖呼吸器症候群（PRRS）ワクチンの地域別市場規模 - 北米のPIG豚繁殖呼吸器症候群（PRRS）ワクチン市場規模（2018年-2029年） - アメリカのPIG豚繁殖呼吸器症候群（PRRS）ワクチン市場規模（2018年-2029年） - ヨーロッパのPIG豚繁殖呼吸器症候群（PRRS）ワクチン市場規模（2018年-2029年） - アジア太平洋のPIG豚繁殖呼吸器症候群（PRRS）ワクチン市場規模（2018年-2029年） - 中国のPIG豚繁殖呼吸器症候群（PRRS）ワクチン市場規模（2018年-2029年） - 日本のPIG豚繁殖呼吸器症候群（PRRS）ワクチン市場規模（2018年-2029年） - 韓国のPIG豚繁殖呼吸器症候群（PRRS）ワクチン市場規模（2018年-2029年） - インドのPIG豚繁殖呼吸器症候群（PRRS）ワクチン市場規模（2018年-2029年） - オーストラリアのPIG豚繁殖呼吸器症候群（PRRS）ワクチン市場規模（2018年-2029年） - 中南米のPIG豚繁殖呼吸器症候群（PRRS）ワクチン市場規模（2018年-2029年） - 中東・アフリカのPIG豚繁殖呼吸器症候群（PRRS）ワクチン市場規模（2018年-2029年） ・タイプ別セグメント：CH-1R株、PC株、その他 - 世界のPIG豚繁殖呼吸器症候群（PRRS）ワクチンのタイプ別販売量（2018年-2023年） - 世界のPIG豚繁殖呼吸器症候群（PRRS）ワクチンのタイプ別売上（2018年-2023年） - 世界のPIG豚繁殖呼吸器症候群（PRRS）ワクチンのタイプ別価格 ・用途別セグメント：雌豚、雌豚 - 世界のPIG豚繁殖呼吸器症候群（PRRS）ワクチンの用途別販売量（2018年-2023年） - 世界のPIG豚繁殖呼吸器症候群（PRRS）ワクチンの用途別売上（2018年-2023年） - 世界のPIG豚繁殖呼吸器症候群（PRRS）ワクチンの用途別価格 ・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向 Merck、HIPRA、Sinopharm Animal Health Co., Ltd、Ceva Santé Animale、CAVAC、Bioveta、Jinyu Bio-Technology、Zoetis、Boehringer Ingelheim、Harbin Pharmaceutical Group ・産業チェーンと販売チャネルの分析 - PIG豚繁殖呼吸器症候群（PRRS）ワクチン産業チェーン分析 - PIG豚繁殖呼吸器症候群（PRRS）ワクチンの主要原材料 - PIG豚繁殖呼吸器症候群（PRRS）ワクチンの販売チャネル - PIG豚繁殖呼吸器症候群（PRRS）ワクチンのディストリビューター - PIG豚繁殖呼吸器症候群（PRRS）ワクチンの主要顧客 ・PIG豚繁殖呼吸器症候群（PRRS）ワクチン市場ダイナミクス - PIG豚繁殖呼吸器症候群（PRRS）ワクチンの業界動向 - PIG豚繁殖呼吸器症候群（PRRS）ワクチン市場の成長ドライバ、課題、阻害要因 ・調査成果および結論 ・調査方法とデータソース |
Highlights
The global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine include Merck, HIPRA, Sinopharm Animal Health Co., Ltd, Ceva Santé Animale, CAVAC, Bioveta, Jinyu Bio-Technology, Zoetis and Boehringer Ingelheim, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine.
The PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Merck
HIPRA
Sinopharm Animal Health Co., Ltd
Ceva Santé Animale
CAVAC
Bioveta
Jinyu Bio-Technology
Zoetis
Boehringer Ingelheim
Harbin Pharmaceutical Group
Segment by Type
CH-1R Strain
PC Strain
Others
Segment by Application
Gilts
Sows
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Overview
1.1 Product Overview and Scope of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine
1.2 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Segment by Type
1.2.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Value Comparison by Type (2023-2029)
1.2.2 CH-1R Strain
1.2.3 PC Strain
1.2.4 Others
1.3 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Segment by Application
1.3.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Value by Application: (2023-2029)
1.3.2 Gilts
1.3.3 Sows
1.4 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Estimates and Forecasts
1.4.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue 2018-2029
1.4.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales 2018-2029
1.4.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Competition by Manufacturers
2.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Manufacturers (2018-2023)
2.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Manufacturers (2018-2023)
2.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Average Price by Manufacturers (2018-2023)
2.4 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine, Product Type & Application
2.7 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Competitive Situation and Trends
2.7.1 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Players Market Share by Revenue
2.7.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Retrospective Market Scenario by Region
3.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region: 2018-2029
3.2.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region: 2018-2023
3.2.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region: 2024-2029
3.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Region: 2018-2029
3.3.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Region: 2018-2023
3.3.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Region: 2024-2029
3.4 North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Facts & Figures by Country
3.4.1 North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2018-2029)
3.4.3 North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Facts & Figures by Country
3.5.1 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2018-2029)
3.5.3 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2018-2029)
3.6.3 Asia Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Facts & Figures by Country
3.7.1 Latin America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2018-2029)
3.7.3 Latin America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2018-2029)
3.8.3 Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2018-2029)
4.1.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2018-2023)
4.1.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2024-2029)
4.1.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Type (2018-2029)
4.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type (2018-2029)
4.2.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type (2018-2023)
4.2.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type (2024-2029)
4.2.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Type (2018-2029)
4.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Type (2018-2029)
5 Segment by Application
5.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2018-2029)
5.1.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2018-2023)
5.1.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2024-2029)
5.1.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Application (2018-2029)
5.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application (2018-2029)
5.2.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application (2018-2023)
5.2.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application (2024-2029)
5.2.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Application (2018-2029)
5.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Merck PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 HIPRA
6.2.1 HIPRA Corporation Information
6.2.2 HIPRA Description and Business Overview
6.2.3 HIPRA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.2.4 HIPRA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
6.2.5 HIPRA Recent Developments/Updates
6.3 Sinopharm Animal Health Co., Ltd
6.3.1 Sinopharm Animal Health Co., Ltd Corporation Information
6.3.2 Sinopharm Animal Health Co., Ltd Description and Business Overview
6.3.3 Sinopharm Animal Health Co., Ltd PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Sinopharm Animal Health Co., Ltd PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
6.3.5 Sinopharm Animal Health Co., Ltd Recent Developments/Updates
6.4 Ceva Santé Animale
6.4.1 Ceva Santé Animale Corporation Information
6.4.2 Ceva Santé Animale Description and Business Overview
6.4.3 Ceva Santé Animale PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Ceva Santé Animale PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
6.4.5 Ceva Santé Animale Recent Developments/Updates
6.5 CAVAC
6.5.1 CAVAC Corporation Information
6.5.2 CAVAC Description and Business Overview
6.5.3 CAVAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.5.4 CAVAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
6.5.5 CAVAC Recent Developments/Updates
6.6 Bioveta
6.6.1 Bioveta Corporation Information
6.6.2 Bioveta Description and Business Overview
6.6.3 Bioveta PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Bioveta PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
6.6.5 Bioveta Recent Developments/Updates
6.7 Jinyu Bio-Technology
6.6.1 Jinyu Bio-Technology Corporation Information
6.6.2 Jinyu Bio-Technology Description and Business Overview
6.6.3 Jinyu Bio-Technology PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Jinyu Bio-Technology PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
6.7.5 Jinyu Bio-Technology Recent Developments/Updates
6.8 Zoetis
6.8.1 Zoetis Corporation Information
6.8.2 Zoetis Description and Business Overview
6.8.3 Zoetis PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Zoetis PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
6.8.5 Zoetis Recent Developments/Updates
6.9 Boehringer Ingelheim
6.9.1 Boehringer Ingelheim Corporation Information
6.9.2 Boehringer Ingelheim Description and Business Overview
6.9.3 Boehringer Ingelheim PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Boehringer Ingelheim PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
6.9.5 Boehringer Ingelheim Recent Developments/Updates
6.10 Harbin Pharmaceutical Group
6.10.1 Harbin Pharmaceutical Group Corporation Information
6.10.2 Harbin Pharmaceutical Group Description and Business Overview
6.10.3 Harbin Pharmaceutical Group PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Harbin Pharmaceutical Group PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
6.10.5 Harbin Pharmaceutical Group Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Chain Analysis
7.2 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Production Mode & Process
7.4 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales and Marketing
7.4.1 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Channels
7.4.2 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Distributors
7.5 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Customers
8 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Dynamics
8.1 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Trends
8.2 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Drivers
8.3 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Challenges
8.4 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer